Literature DB >> 14706556

Increased susceptibility to LTP generation and changes in NMDA-NR1 and -NR2B subunits mRNA expression in rat hippocampus after MCH administration.

Mariana Marcela Varas1, Mariela F Pérez, Oscar A Ramírez, Susana R de Barioglio.   

Abstract

The present study attempts to determine which mechanisms underlie the retrograde facilitation of memory induced by microinjection hippocampal melanin-concentrating hormone (MCH) on the inhibitory avoidance paradigm. Previous reports using this test on the hippocampus suggest that NMDA receptor-mediated mechanisms are involved in memory processing and are also necessary for the induction of long-term potentiation (LTP) of the hippocampal dentate gyrus. In addition, alterations in expression of synaptic NMDA subunits in the hippocampus have been associated with memory formation of an inhibitory avoidance task. We have studied the effects of the neuropeptide upon the electrophysiological parameters using hippocampal slices from rats injected with the peptide and tested in step-down tests as well as possible changes in the mRNA expression of NMDA receptor subunits. We postulate that the increased facility to induce LTP, and the overexpression of this N-methyl-D-aspartate mRNA receptor subunits induced by MCH, could be behind the retrograde facilitation observed after MCH hippocampal microinjection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14706556     DOI: 10.1016/j.peptides.2003.09.006

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  9 in total

1.  Major impairments of glutamatergic transmission and long-term synaptic plasticity in the hippocampus of mice lacking the melanin-concentrating hormone receptor-1.

Authors:  Bastien Pachoud; Antoine Adamantidis; Pascal Ravassard; Pierre-Hervé Luppi; Thierry Grisar; Bernard Lakaye; Paul-Antoine Salin
Journal:  J Neurophysiol       Date:  2010-06-30       Impact factor: 2.714

Review 2.  Melanin-concentrating hormone MCH1 receptor antagonists: a potential new approach to the treatment of depression and anxiety disorders.

Authors:  Toshiharu Shimazaki; Takao Yoshimizu; Shigeyuki Chaki
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

3.  Mice lacking Melanin Concentrating Hormone 1 receptor are resistant to seizures.

Authors:  Gregory S Parks; Sean M Okumura; Krupa Gohil; Olivier Civelli
Journal:  Neurosci Lett       Date:  2010-08-13       Impact factor: 3.046

4.  Hypothalamic connectivities predict individual differences in ADT-elicited changes in working memory and quality of life in prostate cancer patients.

Authors:  Shefali Chaudhary; Alicia Roy; Christine Summers; Simon Zhornitsky; Tim Ahles; Chiang-Shan R Li; Herta H Chao
Journal:  Sci Rep       Date:  2022-06-10       Impact factor: 4.996

5.  Identification of a Novel Rat NR2B Subunit Gene Promoter Region Variant and Its Association with Microwave-Induced Neuron Impairment.

Authors:  Li-Feng Wang; Da-Wei Tian; Hai-Juan Li; Ya-Bing Gao; Chang-Zhen Wang; Li Zhao; Hong-Yan Zuo; Ji Dong; Si-Mo Qiao; Yong Zou; Lu Xiong; Hong-Mei Zhou; Yue-Feng Yang; Rui-Yun Peng; Xiang-Jun Hu
Journal:  Mol Neurobiol       Date:  2015-04-28       Impact factor: 5.590

Review 6.  A role for Melanin-Concentrating Hormone in learning and memory.

Authors:  Antoine Adamantidis; Luis de Lecea
Journal:  Peptides       Date:  2009-07-01       Impact factor: 3.750

7.  Neurochemical characterization of neurons expressing melanin-concentrating hormone receptor 1 in the mouse hypothalamus.

Authors:  Melissa J S Chee; Pavlos Pissios; Eleftheria Maratos-Flier
Journal:  J Comp Neurol       Date:  2013-07-01       Impact factor: 3.215

Review 8.  The role of melanin-concentrating hormone in energy homeostasis and mood disorders.

Authors:  Ildiko Antal-Zimanyi; Xavier Khawaja
Journal:  J Mol Neurosci       Date:  2009-05-06       Impact factor: 3.444

Review 9.  The Melanin-Concentrating Hormone as an Integrative Peptide Driving Motivated Behaviors.

Authors:  Giovanne B Diniz; Jackson C Bittencourt
Journal:  Front Syst Neurosci       Date:  2017-05-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.